Vertex Pharmaceuticals' SWOT analysis: biotech giant's stock faces growth challenges
Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...
Know Your Stock: Walchandnagar, one of Ashish Kacholia's pick, is up 52% in a year, but is there a bull case?
In Q2FY25, Walchandnagar's revenue was at Rs 73.44 crore, around 16.5% than a year ago, with a PBT loss of Rs 11.03 crore in ...
Hosted on MSN14m
U.S. tariff war hits Korean stocks, but experts see short-term impact
South Korea’s stock market tumbled on Feb. 3 as the U.S. intensified its tariff war against trade partners. Already grappling ...